SGO Journal Club—Controversial Topics: How do I treat locally advanced endometrial cancer? Let me count the ways…
When: Monday, June 21st, 2021
Time: 7:00 p.m. CT | 8:00 p.m. ET
Approaching locally advanced endometrial cancer can be particularly challenging, given the multiple modalities of treatment (surgery, radiation, systemic therapies) and differing patterns of disease. Several clinical trials have addressed possible treatment strategies with results that inform our decision making at a more personalized level for our patients. Reviewing data from GOG #258 and PORTEC3, our three panelists will discuss their management approaches, followed by opportunity for live Q&A from attendees.
Attendees are also welcome to stick around for up to 30 minutes after the Journal Club to network and further discuss the presentation in small groups.
Joyce Barlin, MD
Anuja Jhingren, MD
Daniela Matei, MD
Leslie Clark, MD
Lee-may Chen, MD
The journal articles are available for download here:
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy